ADMA Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	510.17	426.45	258.22	154.08	80.94
Revenue Growth (YoY)	19.63%	65.16%	67.58%	90.36%	91.72%
Cost of Revenue	217.41	206.9	169.27	118.82	79.77
Gross Profit	292.77	219.55	88.94	35.27	1.17
Selling, General & Admin	91.58	74.12	59.02	52.46	42.9
Depreciation & Amortization Expenses	0.14	0.39	0.72	0.72	0.72
Research & Development	4.76	1.81	3.3	3.61	3.65
Other Operating Expenses	4.84	4.25	4.27	17.84	12.29
Total Operating Expenses	101.32	80.57	67.31	74.63	59.55
Operating Income	191.44	138.98	21.63	-39.37	-58.37
Interest Income	1.87	2.1	1.62	0.05	0.04
Interest Expense	-7.11	-13.93	-25.03	-19.28	-13.06
Other Non-Operating Income (Expense)	-12.34	-14.71	-76.33	-33.84	-13.53
Total Non-Operating Income (Expense)	-17.57	-26.54	-99.74	-53.08	-26.55
Pretax Income	182.66	125.71	-28.24	-65.9	-84.92
Provision for Income Taxes	35.73	-71.96	-	-	-
Net Income	146.93	197.67	-28.24	-65.9	-71.65
Net Income to Common	146.93	197.67	-28.24	-65.9	-71.65
Net Income Growth	-25.67%	-	-	-	-
Shares Outstanding (Basic)	238	233	224	198	140
Shares Outstanding (Diluted)	245	243	224	198	140
Shares Change (YoY)	0.64%	8.65%	13.19%	41.77%	62.03%
EPS (Basic)	0.62	0.85	-0.13	-0.33	-0.51
EPS (Diluted)	0.60	0.81	-0.13	-0.33	-0.51
EPS Growth	-25.93%	-	-	-	-
Shares Outstanding	237.87	236.62	226.06	221.82	195.81
Free Cash Flow	27.82	110.45	4.03	-73.42	-125.88
Free Cash Flow Growth	-74.81%	2641.28%	-	-	-
Free Cash Flow Per Share	0.11	0.45	0.02	-0.37	-0.90
Gross Margin	57.39%	51.48%	34.44%	22.89%	1.45%
Operating Margin	37.53%	32.59%	8.38%	-25.55%	-72.12%
Profit Margin	28.80%	46.35%	-10.94%	-42.77%	-104.92%
FCF Margin	5.45%	25.90%	1.56%	-47.65%	-155.52%
EBITDA	199.54	147.03	29.96	-32.25	-52.88
EBITDA Margin	39.11%	34.48%	11.60%	-20.93%	-65.33%
EBIT	191.44	138.98	21.63	-39.37	-58.37
EBIT Margin	37.53%	32.59%	8.38%	-25.55%	-72.12%
Effective Tax Rate	19.56%	-57.24%	0.00%	0.00%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q